Synthetic prions with novel strain-specified properties.

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Prions are infectious proteins characterized by self-propagating structures.
• Prion strain information is encoded within the folding of the pathological prion protein (PrPSc).
• In vitro generation of de novo prion strains from recombinant PrP (recPrP) into amyloid structures has been demonstrated.

Purpose of the Study:

• To investigate the conformational diversity and biological activities of pathological recPrP amyloids.
• To gain insights into the molecular mechanisms of mammalian prion conversion and propagation.
• To generate infectious materials with distinct conformational structures.

Main Methods:

• Purified recombinant full-length mouse PrP (recMoPrP) and common chemicals were used for prion conversion.
• Two in vitro protocols converted recMoPrP into amyloid fibrils without seeding factors.
• Infectious amyloid preparations were used to infect mouse GT1 and N2a cell lines for characterization.

Main Results:

• Multiple amyloid preparations induced conformational changes in endogenous PrPC, yielding distinct proteinase-resistant PrP forms.
• One preparation generated a synthetic prion with novel strain-specific neuropathological and biochemical properties in vivo.
• The study successfully created infectious prions from purified recombinant PrP without brain extracts.

Conclusions:

• In vitro conversion of purified recombinant PrP can generate infectious prions with diverse conformational and biological properties.
• This methodology provides a novel platform for studying prion strains and conversion mechanisms.
• The findings contribute to understanding prion diseases and developing diagnostic or therapeutic strategies.